Where does Institut Gustave Roussy rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Institut Gustave Roussy ranks #6,447 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Institut Gustave Roussy hold?

Institut Gustave Roussy holds 52 US utility patents granted between 2015 and 2025, spanning 15 technology areas.

What is Institut Gustave Roussy's Innovation Score?

Institut Gustave Roussy has an Innovation Score of 39.8 out of 100 (top 37% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Institut Gustave Roussy's patent grant rate increasing or decreasing?

Institut Gustave Roussy's recent grant velocity is +33% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Institut Gustave Roussy's patents?

Institut Gustave Roussy's patents average 11.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Institut Gustave Roussy patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Institut Gustave Roussy

Q: What technology areas does Institut Gustave Roussy focus on?

Institut Gustave Roussy's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 35 patents. Grants appear in 15 CPC subclasses total.

USPTO PatentsView assignee record - 52 granted patents across 15 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Institut ranks #6,447 of 50,000 tracked US assignees by granted-patent volume, with 52 patents across 15 technology areas.

#6,447
of 50,000 US assignees by volume: Top 37%
by Innovation Score (39.8/100): 11.4
avg claims per patent: +33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6447 · Foreign Corporation #6,447 · 52 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 52 grants
UPPER-Q #6,447/50,000
PHOTO-FINISH I-SHOU UNIVERSITY
CPC-FOCUS A61P · 15 areas
INNOV-THIN 39.8/100
CLAIMS-PAR 11.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: I-shou University (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Astute Medical · near

40
Birkenstock IP · near

40
Institut Gustave Rou… · this assignee

40
Nippon Steel & Sumik… · near

40
Polymer Technology S… · near

40
3D Lighting Innovati… · lowest

7

What this shows Institut Gustave Roussy stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-THIN, CLAIMS-PAR, TYPE-FRNCORP, VEL-UP, BOOK-FULL. Volume places it #6,447 of 50,000; Innovation Score 39.8/100 sits in the top 37% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is I-shou University (±0 grants).

Portfolio overview

Institut Gustave Roussy has been granted 52 US utility patents between 2015 and 2025, placing Institut Gustave Roussy at #6,447 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.4 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Institut Gustave Roussy is one of the more focused assignees in the PatentsView dataset. By volume, Institut sits between I-shou University (52 patents, rank #6,442) and Jenoptik Optical Systems Gmbh (52 patents, rank #6,450) - the closest US assignees by grant volume. The composite Innovation Score of 39.8/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 28 grants, compared with 21 in the 2015–2019 window, a +33% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Institut Gustave Roussy's 11.4 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 15 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

I-shou University

52
IFM

52
Inertech IP

52
INJE University I…

52
Incontact

52
Isis Pharmaceutic…

52
JBF Interlude 2009

52
Jenoptik Optical…

52
Institut Gustave… ◀

52

What this shows Institut holds 52 patents at rank #6,446, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Institut

By rank, the assignees closest to #6,446 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Institut's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Institut, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Astute Medical, Inc. 40 Nippon Steel & Sumikin Stainless Steel Corporation 40 Birkenstock IP Gmbh 40 Polymer Technology Systems, Inc. 40

Similar claim depth

Nearest assignees by average claims per patent (11.4 here).

Silgan Dispensing Systems Corporation 11.4 avg Tokyo Visionary Optics Co., Ltd. 11.4 avg Endress+hauser Process Solutions Ag 11.4 avg New York Air Brake Llc 11.4 avg

Institut's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Institut Gustave Roussy patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	5.8%
2016	3	5.8%
2017	7	13.5%
2018	5	9.6%
2019	3	5.8%
2020	5	9.6%
2021	9	17.3%
2022	6	11.5%
2023	5	9.6%
2024	3	5.8%
2025partial year	3	5.8%

Which technologies does Institut Gustave Roussy patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 35

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 35

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 23

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 22

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 17

C07K - PEPTIDES 15

C07F - ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM 5

C07D - HETEROCYCLIC COMPOUNDS 4

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 3

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 2

C07H - SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 1

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 1

A61G - TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS ; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES 1

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 1

Top 15 of 15 technology areas

Where it ranks

Overall rank by patents

#6,447

of 50,000 tracked assignees

Innovation Score

39.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.